These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30242058)

  • 1. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
    Wang Z; Gao L; Xiao L; Kong L; Shi H; Tian X; Zhao L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30242058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload.
    Zong J; Li FF; Liang K; Dai R; Zhang H; Yan L; Liu JL; Xu LH; Qian WH
    Cell Physiol Biochem; 2018; 48(1):75-86. PubMed ID: 30001530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
    Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
    Zhang N; Wei WY; Yang Z; Che Y; Jin YG; Liao HH; Wang SS; Deng W; Tang QZ
    Cell Physiol Biochem; 2017; 42(4):1313-1325. PubMed ID: 28700997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
    Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
    Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
    Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
    Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
    Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
    Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.
    Shen DF; Tang QZ; Yan L; Zhang Y; Zhu LH; Wang L; Liu C; Bian ZY; Li H
    Br J Pharmacol; 2010 Feb; 159(4):970-81. PubMed ID: 20105174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy.
    Xu T; Tang H; Zhang B; Cai C; Liu X; Han Q; Zou L
    Int J Clin Exp Pathol; 2015; 8(1):530-40. PubMed ID: 25755743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
    Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
    Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad Nuclear Interacting Protein 1 Acts as a Protective Regulator of Pressure Overload-Induced Pathological Cardiac Hypertrophy.
    Lu YY; Xu DC; Zhao YF; Zhu GF; Zhu MY; Liu WJ; Yu XJ; Chen W; Liu Z; Xu YW
    J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27912208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SARAF Ameliorates Pressure Overload-Induced Cardiac Hypertrophy Through Suppressing STIM1-Orai1 in Mice.
    Dai F; Zhang Y; Wang Q; Li D; Yang Y; Ma S; Yang D
    Cell Physiol Biochem; 2018; 47(2):817-826. PubMed ID: 29807359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.
    Takano APC; Munhoz CD; Moriscot AS; Gupta S; Barreto-Chaves MLM
    J Mol Med (Berl); 2017 Jun; 95(6):671-682. PubMed ID: 28161820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
    Jiang DS; Liu Y; Zhou H; Zhang Y; Zhang XD; Zhang XF; Chen K; Gao L; Peng J; Gong H; Chen Y; Yang Q; Liu PP; Fan GC; Zou Y; Li H
    Hypertension; 2014 Apr; 63(4):713-22. PubMed ID: 24396025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.